Baseline Imaging Derived Predictive Factors of Response Following [<sup>177</sup>Lu]Lu-PSMA-617 Therapy in Salvage Metastatic Castration-Resistant Prostate Cancer: A Lesion- and Patient-Based Analysis

Baseline Imaging Derived Predictive Factors of Response Following [<sup>177</sup>Lu]Lu-PSMA-617 Therapy in Salvage Metastatic Castration-Resistant Prostate Cancer: A Lesion- and Patient-Based Analysis

Earlier studies have mostly identified pre-therapeutic clinical and laboratory parameters for the prediction of treatment response to [<sup>177</sup>Lu]Lu-PSMA-617 in metastatic castration resistant prostate cancer patients (mCRPC). The current study investigated whether imaging-derived...

Full description

Bibliographic Details
Main Authors: Esmée C. A. van der Sar, Adinda J. S. Kühr, Sander C. Ebbers, Andrew M. Henderson, Bart de Keizer, Marnix G. E. H. Lam, Arthur J. A. T. Braat
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Biomedicines
Subjects:
prostate cancer
lutetium
radio-ligand therapy
prostate specific membrane antigen
predictors
Online Access:https://www.mdpi.com/2227-9059/10/7/1575

Internet

https://www.mdpi.com/2227-9059/10/7/1575

Similar Items